Shares of Vivos Therapeutics Inc. (VVOS) have gained more than 50% over the last 2 months and trade around $4. However, this is still a 50% decline from the 52-week high of $9.13, which was recorded last January.
This medical technology and services company provides proprietary oral appliances and therapeutic treatments designed to non-surgically address specific maxillofacial and developmental abnormalities of the mouth and jaws, which are often linked to breathing and sleep disorders like mild to severe obstructive sleep apnea (OSA) and snoring in adults.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com